Infectious Diseases On The Upswing A Global Health Concern : Strategic Insights Driving Infectious Disease Therapeutics Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Infectious Disease Therapeutics Market Size By 2025?
The market size of infectious disease therapeutics has seen a considerable surge in its growth over the past few years. The market, which was worth $141.08 billion in 2024, is anticipated to reach $151.04 billion in 2025 with a compound annual growth rate (CAGR) of 7.1%. A multitude of factors have contributed to this growth during the historic period, these include an increased occurrence of infectious diseases, a surge in viral disease cases, enhanced awareness towards diagnosis, an escalated demand for swift and effective diagnostic testing, a rise in demand for economically viable generic drugs, increased incidences of infectious diseases, and an augmented significance of antimicrobial stewardship.

How Big Is the Infectious Disease Therapeutics Market Size Expected to Grow by 2029?
The market size for therapeutics targeting infectious diseases is projected to experience significant expansion in the coming years, surging to $196.5 billion by 2029 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during this forecast period can be associated with factors such as increasing investment in the sector, the expansion of clinical trial studies, a rising number of these trials, heightened attention on preventing infectious diseases, growing consciousness about the importance of early diagnosis and an increase in both awareness and funding. Major trends expected during this period encompass partnerships, approvals of new products, continued investment, and the progression of research and developmental activities in therapeutics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

Which Key Market Drivers Powering Infectious Disease Therapeutics Market Expansion and Growth?
The surge in occurrences of infectious diseases is projected to fuel the expansion of the infectious disease therapeutics market in the future. Infectious diseases are conditions initiated by disease-causing microorganisms such as bacteria, viruses, fungi, parasites, or prions. Several factors like environmental changes and disruption, antimicrobial resistance, compromised immune systems, increased interaction with animals, and ecological imbalances lead to the rise of these diseases. The therapeutics for infectious diseases play a pivotal role in infection treatment, lowering morbidity and mortality rates, and managing the transmission of contagious diseases among individuals and population groups. For example, the Centers for Disease Control and Prevention, a government agency based in the US, stated in November 2023 that the US reported 8,331 tuberculosis (TB) cases in 2022. These cases represent an incidence rate of 2.5 per 100,000 individuals, indicating a 5.9% increase in case numbers and a 5.5% rise in the rate of incidence compared to 2021. Hence, this rising prevalence of infectious diseases triggers the growth of the infectious disease therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Infectious Disease Therapeutics Market?
Significant corporations active in the infectious disease therapeutics market are funding research into infectious disease medication. Their objective is to pioneer more potent treatments, fight against antimicrobial resistance, broaden their range of offerings, and respond to emerging infectious threats. These investments aspire to enhance patient outcomes, fulfil unaddressed medical necessities, and support worldwide public health initiatives to regulate and manage infectious diseases. For example, in June 2022, GSK, a healthcare firm based in the UK, invested £1 billion ($1.09 billion) to proactively tackle infectious diseases in nations with lower income. This venture aims to amplify research and development attempts to battle illnesses that predominantly impact these areas. The inequality in health research funding and resources between wealthy nations and low to middle-income countries emphasises the critical need for such assertive investments to justly improve population health.

What Are the Emerging Segments in the Infectious Disease Therapeutics Market?
The infectious disease therapeutics market covered in this report is segmented -

1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

Subsegments:
1) By Drugs - Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines - Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp

Who Are the Global Leaders in the Infectious Disease Therapeutics Market?
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.

Which are the Top Profitable Regional Markets for the Infectious Disease Therapeutics Industry?
North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15594

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.